These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 21868778)

  • 1. Insulin pump therapy with automated insulin suspension in response to hypoglycemia: reduction in nocturnal hypoglycemia in those at greatest risk.
    Choudhary P; Shin J; Wang Y; Evans ML; Hammond PJ; Kerr D; Shaw JA; Pickup JC; Amiel SA
    Diabetes Care; 2011 Sep; 34(9):2023-5. PubMed ID: 21868778
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevention of hypoglycemia by using low glucose suspend function in sensor-augmented pump therapy.
    Danne T; Kordonouri O; Holder M; Haberland H; Golembowski S; Remus K; Bläsig S; Wadien T; Zierow S; Hartmann R; Thomas A
    Diabetes Technol Ther; 2011 Nov; 13(11):1129-34. PubMed ID: 21827318
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Usage and effectiveness of the low glucose suspend feature of the Medtronic Paradigm Veo insulin pump.
    Agrawal P; Welsh JB; Kannard B; Askari S; Yang Q; Kaufman FR
    J Diabetes Sci Technol; 2011 Sep; 5(5):1137-41. PubMed ID: 22027306
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of glucose responses to automated insulin suspension with sensor-augmented pump therapy.
    Ly TT; Nicholas JA; Retterath A; Davis EA; Jones TW
    Diabetes Care; 2012 Jul; 35(7):1462-5. PubMed ID: 22584133
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effectiveness of the low-glucose suspend feature of insulin pump during fasting during Ramadan in type 1 diabetes mellitus.
    Elbarbary NS
    Diabetes Metab Res Rev; 2016 Sep; 32(6):623-33. PubMed ID: 26789012
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reduction in duration of hypoglycemia by automatic suspension of insulin delivery: the in-clinic ASPIRE study.
    Garg S; Brazg RL; Bailey TS; Buckingham BA; Slover RH; Klonoff DC; Shin J; Welsh JB; Kaufman FR
    Diabetes Technol Ther; 2012 Mar; 14(3):205-9. PubMed ID: 22316089
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Threshold-based insulin-pump interruption for reduction of hypoglycemia.
    Bergenstal RM; Klonoff DC; Garg SK; Bode BW; Meredith M; Slover RH; Ahmann AJ; Welsh JB; Lee SW; Kaufman FR;
    N Engl J Med; 2013 Jul; 369(3):224-32. PubMed ID: 23789889
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk for ketonaemia in type 1 diabetes pregnancies with sensor-augmented pump therapy with predictive low glucose suspend compared with low glucose suspend: a crossover RCT.
    Benhalima K; van Nes F; Laenen A; Gillard P; Mathieu C
    Diabetologia; 2021 Dec; 64(12):2725-2730. PubMed ID: 34647140
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and safety of sensor augmented insulin pump therapy with low-glucose suspend feature in older adults: A retrospective study in Bogota, Colombia.
    Morros-González E; Gómez AM; Henao Carrillo DC; Ursida V; Serrano S; Rondón Sepúlveda MA; Muñoz Velandia OM
    Diabetes Metab Syndr; 2021; 15(3):649-653. PubMed ID: 33813236
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The ASPIRE study: design and methods of an in-clinic crossover trial on the efficacy of automatic insulin pump suspension in exercise-induced hypoglycemia.
    Brazg RL; Bailey TS; Garg S; Buckingham BA; Slover RH; Klonoff DC; Nguyen X; Shin J; Welsh JB; Lee SW
    J Diabetes Sci Technol; 2011 Nov; 5(6):1466-71. PubMed ID: 22226267
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A cost-effectiveness analysis of sensor-augmented insulin pump therapy and automated insulin suspension versus standard pump therapy for hypoglycemic unaware patients with type 1 diabetes.
    Ly TT; Brnabic AJ; Eggleston A; Kolivos A; McBride ME; Schrover R; Jones TW
    Value Health; 2014 Jul; 17(5):561-9. PubMed ID: 25128049
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-Term Efficacy and Safety of Sensor Augmented Insulin Pump Therapy with Low-Glucose Suspend Feature in Patients with Type 1 Diabetes.
    Gómez AM; Marín Carrillo LF; Muñoz Velandia OM; Rondón Sepúlveda MA; Arévalo Correa CM; Mora Garzón E; Cuervo Diaz MC; Henao Carrillo DC
    Diabetes Technol Ther; 2017 Feb; 19(2):109-114. PubMed ID: 28001445
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The PILGRIM study: in silico modeling of a predictive low glucose management system and feasibility in youth with type 1 diabetes during exercise.
    Danne T; Tsioli C; Kordonouri O; Blaesig S; Remus K; Roy A; Keenan B; Lee SW; Kaufman FR
    Diabetes Technol Ther; 2014 Jun; 16(6):338-47. PubMed ID: 24447074
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characteristics of Automated Insulin Suspension and Glucose Responses with the Predictive Low-Glucose Management System.
    Abraham MB; Smith GJ; Nicholas JA; Fairchild JM; King BR; Ambler GR; Cameron FJ; Davis EA; Jones TW;
    Diabetes Technol Ther; 2019 Jan; 21(1):28-34. PubMed ID: 30585769
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glycemia, Treatment Satisfaction, Cognition, and Sleep Quality in Adults and Adolescents with Type 1 Diabetes When Using a Closed-Loop System Overnight Versus Sensor-Augmented Pump with Low-Glucose Suspend Function: A Randomized Crossover Study.
    Sharifi A; De Bock MI; Jayawardene D; Loh MM; Horsburgh JC; Berthold CL; Paramalingam N; Bach LA; Colman PG; Davis EA; Grosman B; Hendrieckx C; Jenkins AJ; Kumareswaran K; Kurtz N; Kyoong A; MacIsaac RJ; Speight J; Trawley S; Ward GM; Roy A; Jones TW; O'Neal DN
    Diabetes Technol Ther; 2016 Dec; 18(12):772-783. PubMed ID: 27835037
    [TBL] [Abstract][Full Text] [Related]  

  • 16. "Let the Algorithm Do the Work": Reduction of Hypoglycemia Using Sensor-Augmented Pump Therapy with Predictive Insulin Suspension (SmartGuard) in Pediatric Type 1 Diabetes Patients.
    Biester T; Kordonouri O; Holder M; Remus K; Kieninger-Baum D; Wadien T; Danne T
    Diabetes Technol Ther; 2017 Mar; 19(3):173-182. PubMed ID: 28099035
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Predictive Low Glucose Management System in Prevention of Clinically Significant Hypoglycemia in Type 1 Diabetes. A Preliminary Study Identifying the Most Common Events Leading Up to Hypoglycemia During Insulin Pump Therapy.
    Thomakos P; Mitrakou A; Kepaptsoglou O; Taraoune I; Barreto C; Zoupas CS
    Exp Clin Endocrinol Diabetes; 2021 May; 129(5):385-389. PubMed ID: 30986882
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of sensor-augmented insulin pump therapy and automated insulin suspension vs standard insulin pump therapy on hypoglycemia in patients with type 1 diabetes: a randomized clinical trial.
    Ly TT; Nicholas JA; Retterath A; Lim EM; Davis EA; Jones TW
    JAMA; 2013 Sep; 310(12):1240-7. PubMed ID: 24065010
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of sensor-augmented pump therapy with predictive low-glucose management on hypoglycemia and glycemic control in patients with type 1 diabetes mellitus: 1-year follow-up.
    Gómez AM; Henao DC; Taboada LB; Leguizamón G; Rondón MA; Muñoz OM; García-Jaramillo MA; León Vargas FM
    Diabetes Metab Syndr; 2019; 13(4):2625-2631. PubMed ID: 31405686
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ASPIRE In-Home: rationale, design, and methods of a study to evaluate the safety and efficacy of automatic insulin suspension for nocturnal hypoglycemia.
    Klonoff DC; Bergenstal RM; Garg SK; Bode BW; Meredith M; Slover RH; Ahmann A; Welsh JB; Lee SW
    J Diabetes Sci Technol; 2013 Jul; 7(4):1005-10. PubMed ID: 23911183
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.